» Articles » PMID: 28705945

Alcohol Consumption As a Risk Factor for Tuberculosis: Meta-analyses and Burden of Disease

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2017 Jul 15
PMID 28705945
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Meta-analyses of alcohol use, alcohol dosage and alcohol-related problems as risk factors for tuberculosis incidence were undertaken. The global alcohol-attributable tuberculosis burden of disease was also re-estimated.Systematic searches were conducted, reference lists were reviewed and expert consultations were held to identify studies. Cohort and case-control studies were included if there were no temporal violations of exposure and outcome. Risk relations (RRs) were pooled by using categorical and dose-response meta-analyses. The alcohol-attributable tuberculosis burden of disease was estimated by using alcohol-attributable fractions.36 of 1108 studies were included. RRs for alcohol use and alcohol-related problems were 1.35 (95% CI 1.09-1.68; I: 83%) and 3.33 (95% CI 2.14-5.19; 87%), respectively. Concerning alcohol dosage, tuberculosis risk rose as ethanol intake increased, with evidence of a threshold effect. Alcohol consumption caused 22.02 incident cases (95% CI 19.70-40.77) and 2.35 deaths (95% CI 2.05-4.79) per 100 000 people from tuberculosis in 2014. Alcohol-attributable tuberculosis incidence increased between 2000 and 2014 in most high tuberculosis burden countries, whereas mortality decreased.Alcohol consumption was associated with an increased risk of tuberculosis in all meta-analyses. It was consequently a major contributor to the tuberculosis burden of disease.

Citing Articles

Tuberculosis incidence, deaths and disability-adjusted life years in children and adolescence, 1990-2021: Results from the Global Burden of Disease Study 2021.

Li X, Li Y, Guo L, Chen Y, Wang G, Zhang H PLoS One. 2025; 20(3):e0317880.

PMID: 40063613 PMC: 11892809. DOI: 10.1371/journal.pone.0317880.


Factors driving adolescent tuberculosis incidence by age and sex in 30 high-tuberculosis burden countries: a mathematical modelling study.

Chiang S, Murray M, Kay A, Dodd P BMJ Glob Health. 2025; 10(3).

PMID: 40044460 PMC: 11883532. DOI: 10.1136/bmjgh-2024-015368.


Prevalence and Factors Associated with Substance Use Among Patients with Tuberculosis in Uganda.

Olum R, Nakkonde D, Nassanga G, Zalwango S, Sekandi J Res Sq. 2025; .

PMID: 39975935 PMC: 11838757. DOI: 10.21203/rs.3.rs-5927600/v1.


Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study.

Rotundo S, Nistico S, Morrone H, Gallo L, Dodaro S, Papola C J Clin Tuberc Other Mycobact Dis. 2025; 38:100512.

PMID: 39949587 PMC: 11821412. DOI: 10.1016/j.jctube.2025.100512.


Sequelae of Immunocompromised Host Pneumonia.

Salwen B, Mascarenhas E, Horne D, Crothers K, Zifodya J Clin Chest Med. 2025; 46(1):49-60.

PMID: 39890292 PMC: 11790256. DOI: 10.1016/j.ccm.2024.10.004.


References
1.
Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias H . WHO's new end TB strategy. Lancet. 2015; 385(9979):1799-1801. DOI: 10.1016/S0140-6736(15)60570-0. View

2.
Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

3.
Mori M, Leonardson G, Welty T . The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians. Arch Intern Med. 1992; 152(3):547-50. View

4.
Lonnroth K, Castro K, Chakaya J, Chauhan L, Floyd K, Glaziou P . Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010; 375(9728):1814-29. DOI: 10.1016/S0140-6736(10)60483-7. View

5.
Coker R, Mckee M, Atun R, Dimitrova B, Dodonova E, Kuznetsov S . Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ. 2005; 332(7533):85-7. PMC: 1326930. DOI: 10.1136/bmj.38684.687940.80. View